Growth Metrics

Lisata Therapeutics (LSTA) Gains from Investment Securities (2016 - 2025)

Lisata Therapeutics filings provide 10 years of Gains from Investment Securities readings, the most recent being $10000.0 for Q2 2025.

  • For the quarter ending Q2 2025, Gains from Investment Securities changed N/A year-over-year to $10000.0, compared with a TTM value of $253000.0 through Dec 2025, down 7.66%, and an annual FY2025 reading of $253000.0, down 7.66% over the prior year.
  • Gains from Investment Securities hit $10000.0 in Q2 2025 for Lisata Therapeutics, down from $243000.0 in the prior quarter.
  • The five-year high for Gains from Investment Securities was $243000.0 in Q1 2025, with the low at -$91000.0 in Q4 2023.
  • Median Gains from Investment Securities over the past 3 years was $94000.0 (2023), compared with a mean of $75285.7.
  • The sharpest move saw Gains from Investment Securities skyrocketed 4833.33% in 2024, then surged 71.13% in 2025.
  • Year by year, Gains from Investment Securities stood at -$91000.0 in 2023, then skyrocketed by 245.05% to $132000.0 in 2024, then plummeted by 92.42% to $10000.0 in 2025.
  • According to Business Quant data, Gains from Investment Securities over the past three periods came in at $10000.0, $243000.0, and $132000.0 for Q2 2025, Q1 2025, and Q4 2024 respectively.